小児患者におけるアトピー性皮膚炎の観察評価

基本情報

NCT ID

NCT03687359

ステータス

実施中（募集終了）

試験のフェーズ

-

試験タイプ

観察

目標被験者数

1,860

治験依頼者名

Sanofi

概要

Primary Objectives: * To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable. * To evaluate the time-course of AD and selected atopic comorbidities. Secondary Objectives: * To characterize disease burden and unmet need. * To describe real-world treatment patterns (eg, dosing regimens, treatment duration, and reasons for discontinuation and/or switching). * To document the real-world effectiveness and safety of treatments.

対象疾患

介入

依頼者（Sponsor）